Nonoperating Income (Expense) in USD of BioAge Labs, Inc. from Q3 2023 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
BioAge Labs, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from Q3 2023 to Q3 2025.
  • BioAge Labs, Inc. Nonoperating Income (Expense) for the quarter ending September 30, 2025 was $2.97M, a 121% increase year-over-year.
  • BioAge Labs, Inc. Nonoperating Income (Expense) for the twelve months ending September 30, 2025 was $13.9M.
  • BioAge Labs, Inc. annual Nonoperating Income (Expense) for 2024 was $7.09M.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)
Nonoperating Income (Expense), Annual (USD)

BioAge Labs, Inc. Quarterly Nonoperating Income (Expense) (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 $13.9M $2.97M +$1.63M +121% Jul 1, 2025 Sep 30, 2025 10-Q 2025-11-06
Q2 2025 $12.3M $3.21M +$1.52M +90% Apr 1, 2025 Jun 30, 2025 10-Q 2025-08-06
Q1 2025 $10.8M $3.52M +$3.7M Jan 1, 2025 Mar 31, 2025 10-Q 2025-05-06
Q4 2024 $7.09M $4.23M Oct 1, 2024 Dec 31, 2024 10-K 2025-03-20
Q3 2024 $1.34M +$6.08M Jul 1, 2024 Sep 30, 2024 10-Q 2025-11-06
Q2 2024 $1.69M Apr 1, 2024 Jun 30, 2024 10-Q 2025-08-06
Q1 2024 -$179K Jan 1, 2024 Mar 31, 2024 10-Q 2025-05-06
Q3 2023 -$4.74M Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-07

BioAge Labs, Inc. Annual Nonoperating Income (Expense) (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $7.09M +$22.5M Jan 1, 2024 Dec 31, 2024 10-K 2025-03-20
2023 -$15.5M Jan 1, 2023 Dec 31, 2023 10-K 2025-03-20
* An asterisk sign (*) next to the value indicates that the value is likely invalid.